Evaluation of Different G6PD Testing Platforms

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

700 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-04-30

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study the investigators propose to evaluate the performance of several G6PD testing platforms.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Validation of New G6PD Point of Care Tests Against Gold Standard Quantitative

NCT02625285

Validation Biosensors Genotyping

COMPLETED

Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.

NCT00154960

Spinal Muscular Atrophy Neonatal Hyperbilirubinemia Colon Cancer

UNKNOWN

Significant Pathology Associated With Crossed Leg Sign

NCT01569555

Pathology

UNKNOWN

Podocyturia - Predictor of Renal Dysfunction in Fabry Nephropathy

NCT02994303

Fabry Disease

UNKNOWN

Crossed Leg Sign and it's Correlation With Significant Pathology

NCT01569542

Pathology

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study we propose to evaluate the performance of several G6PD testing platforms. We will also determine the concordance between point-of-care G6PD tests and the spectrophotometric gold standard. This study will also access the sensitivity and specificity between the point-of-care G6PD tests. This study will take place in Indonesia, specifically in the SW Sumba region. We will enroll 700 volunteers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glucose-6-Phosphate Dehydrogenase Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

G6PD testing

Blood samples will be tested for G6PD activity levels

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects must be at least five years of age
* Patient / parental consent
* Patient willing to allow donated sample to be used in future research

Exclusion Criteria

* Patients with severe malaria or other severe illness
* Patients who received a blood transfusion in the last three months
* Patients unwilling to allow donated blood to be used in future research

Minimum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes